The drug mycophenolate is in a class of medications called immunosuppressive agents. It works by weakening the body's immune system so it will not attack and reject a transplanted organ.
The list of mycophenolate-containing medicines includes CellCept (mycophenolate mofetil), Myfortic (mycophenolic acid), and any generic mycophenolate mofetil or mycophenolic acid products.
Questions and Answers: FDA Approves a Single Shared Risk Evaluation and Mitigation Strategy (REMS) for Mycophenolate-containing Medicines
Information for Healthcare Professionals: Immunosuppressant Drugs: Required Labeling Changes[ARCHIVED]
Risk Evaluation and Mitigation Strategy (REMS) Under Review for CellCept and Myfortic Information for Healthcare Professionals: Mycophenolate Mofetil (marketed as CellCept) and Mycophenolic Acid (marketed as Myfortic)[ARCHIVED]
Communication About an Ongoing Safety Review of CellCept (mycophenolate mofetil) and Myfortic (mycophenolic acid)[ARCHIVED]